News | Digital Radiography (DR) | November 25, 2019

Canon Introduces Two New Wireless Detectors

The CXDI-702C and CXDI-402C wireless detectors have been FDA-cleared

Canon U.S.A., Inc. introduced the new CXDI-702C and CXDI-402C wireless detectors

November 25, 2019 – Canon U.S.A., Inc. introduced the new CXDI-702C and CXDI-402C wireless detectors. These new detectors offer customers the superb quality and reliability, as well as the features and accessories, of the CXDI-710C, CXDI-810C and CXDI-410C wireless detectors. Both have received FDA 510(k) clearance.

As seen by their open, curved external cover, the CXDI-702C and CXDI-402C wireless detectors were designed by Canon Inc. with usability in mind, helping to facilitate both the user and patient experience. With the lightweight handgrips, users are able to comfortably and easily hold and handle the detectors on all four sides. Additionally, the detectors were designed by Canon Inc. to provide certain limited protection from dust and splashed water with limited ingress of both permitted.  

“We are excited to add the CXDI-702C and CXDI-402C wireless detectors to the Canon U.S.A. product portfolio as they align with Canon’s commitment to developing high-quality diagnostic imaging devices with the goal of helping to improve the quality of life for patients,” said Tsuneo Imai, vice president and general manager, Healthcare Solutions Division, Business Information Communications Group, Canon U.S.A., Inc. “These detectors were designed by Canon Inc. to meet clinical professionals’ demand for a cost-effective detector technology with the ability to benefit multiple types of diagnostic imaging facilities, and Canon U.S.A. is happy to make them available to its customers.”

Canon U.S.A. invites guests at Radiological Social of North America (RSNA) Annual Meeting 2019, taking place Saturday, November 30, 2019 through Friday, December 5, 2019 at McCormick Place in Chicago, to see the new CXDI-702C and CXDI-402C wireless detectors firsthand in the Canon U.S.A. booth #3706. The booth will also feature additional products from the Canon line of diagnostic imaging devices.

For more information: https://www.usa.canon.com/dr

Related Content

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
Carestream Health will offer insights on technology, innovative new products and research in medical imaging through a new webinar series titled Carestream Talks. #RSNA20
News | Radiology Education | October 14, 2020
October 14, 2020 — Carestrea